NorthSea Therapeutics B.V.
7 clinical trials · Sponsor
◉ Watch NorthSea Therapeutics B.V.
| Record | Firm | Date |
|---|---|---|
| A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD). (NCT05919680) | NorthSea Therapeutics B.V. | 2024-01-15 |
| Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia (NCT05889156) | NorthSea Therapeutics B.V. | 2023-06-30 |
| Open-label Study to Evaluate the Effects of NST-1024 on the PK of Multiple Drugs in Healthy Subjects (NCT05368831) | NorthSea Therapeutics B.V. | 2022-07-19 |
| A Phase 1, First Time in Humans Study of NST-1024 (NCT04630366) | NorthSea Therapeutics B.V. | 2020-10-27 |
| A Phase 2b Study of Icosabutate in Fatty Liver Disease (NCT04052516) | NorthSea Therapeutics B.V. | 2019-07-17 |
| A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval (NCT03577275) | NorthSea Therapeutics B.V. | 2018-06-15 |
Track NorthSea Therapeutics B.V. automatically
Every clearance here is in the API, with alerts when new ones post.